These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 14088467)
1. THROMBOEMBOLIC PHENOMENA ASSOCIATED WITH ORAL CONTRACEPTIVES. GOLPIRA A Md State Med J; 1963 Dec; 12():605-7. PubMed ID: 14088467 [No Abstract] [Full Text] [Related]
2. THROMBOEMBOLIC PHENOMENON ASSOCIATED WITH THE USE OF PROGESTATIONAL DRUGS. COHEN MG; SAJID MH Del Med J; 1964 Apr; 36():81-2 PASSIM. PubMed ID: 14140026 [No Abstract] [Full Text] [Related]
3. THROMBOEMBOLIC DISEASE ASSOCIATED WITH NORETHYNODREL. REPORT OF SIX CASES. SCHATZ IJ; SMITH RF; BRENEMAN GM; BOWER GC JAMA; 1964 May; 188():493-5. PubMed ID: 14159064 [No Abstract] [Full Text] [Related]
4. THROMBOEMBOLIC DISEASE IN A PATIENT RECEIVING NORETHYNODREL. HERSHFIELD BM N Y State J Med; 1964 Jan; 64():302-4. PubMed ID: 14103684 [No Abstract] [Full Text] [Related]
5. Thromboembolic disease associated with norethynodrel: report of six cases. Schatz IJ; Smith RF; Breneman GM; Bower GC JAMA; 1964 May; 188(6):493-5. PubMed ID: 12255392 [TBL] [Abstract][Full Text] [Related]
8. HORMONAL CONTROL OF CONCEPTION. BUXTON CL; KASE N Practitioner; 1964 Mar; 192():343-50. PubMed ID: 14130829 [No Abstract] [Full Text] [Related]
9. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
10. Oral contraception and venous thrombosis. Tyler ET JAMA; 1963 Jul; 185(2):131-2. PubMed ID: 12255487 [TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and thromboembolic disease. I. Prospective and retrospective studies. Drill VA JAMA; 1972 Jan; 219(5):583-92. PubMed ID: 5066803 [No Abstract] [Full Text] [Related]
12. Thromboembolic disease and the steroidal content of oral contraceptives. Swyer GI Res Reprod; 1970 Jul; 2(4):1. PubMed ID: 12254979 [TBL] [Abstract][Full Text] [Related]
13. An analysis of the reported association of oral contraceptives to thromboembolic disease. Odell WD West J Med; 1975 Jan; 122(1):26-33. PubMed ID: 1089003 [No Abstract] [Full Text] [Related]
14. ORAL CONTRACEPTIVES AND LIVER DAMAGE. ADLERCREUTZ H Br Med J; 1964 Oct; 2(5417):1133. PubMed ID: 14198736 [No Abstract] [Full Text] [Related]
15. SEVERE UTERINE BLEEDING FOLLOWING THE PROLONGED USE OF NORETHYNODREL-MESTRANOL. KAHN S; NOVICK O; DIAMOND S Obstet Gynecol; 1965 Mar; 25():298-301. PubMed ID: 14268008 [No Abstract] [Full Text] [Related]
16. A PSYCHIATRIC EVALUATION OF THE USE OF ORAL CONTRACEPTIVES. A STUDY OF 250 PRIVATE PATIENTS. ZELL JR; CRISP WE Obstet Gynecol; 1964 May; 23():657-61. PubMed ID: 14196391 [No Abstract] [Full Text] [Related]
17. [RESULTS IN THE USE OF ORAL OVULATION INHIBITORS (ORAL CONTRACEPTIVES)]. SWAAB LI Ned Tijdschr Geneeskd; 1964 May; 108():1070-6. PubMed ID: 14156330 [No Abstract] [Full Text] [Related]
18. CHOLESTATIC JAUNDICE COMPLICATING PREGNANCY: RECURRENCE AFTER NORETHYNODREL WITH ETHYNYLESTRADIOL (ENOVID). ELLIOTT AJ; HENDRY J Can Med Assoc J; 1965 Feb; 92(7):344-5. PubMed ID: 14243870 [No Abstract] [Full Text] [Related]